IDEX Biometrics consolidates operations in Norway
IDEX Biometrics consolidates operations in Norway
IDEX Biometrics ASA (Euronext Oslo Børs: IDEX; Oslo, Norway. 23 October 2026) today announces that it will consolidate its organization in Norway. The company’s UK development site in Farnborough will be closed, and engineering and technology activities will be brought together with management, product, sales, marketing and operations in Oslo.
The next phase is closely tied to customers and partners, and is best run from one location. The new structure is expected to reduce IDEX’s annual operating costs by approximately NOK 20 million on a net basis, with effect from November 2026.
“This is in line with our communicated strategy of creating a strong product company. I am excited for the next phase and opportunities this will bring to IDEX,” said Kjell-Arne Besseberg, CEO of IDEX Biometrics.
IDEX
Identify yourself as a human
CONTACTS
Anders Storbråten, Executive Chairman, Tel: +47 416 38 582 E-mail: ir@idexbiometrics.com
ABOUT US
IDEX Biometrics ASA (OSE: IDEX) develops and makes fingerprint biometric cards for access control, digital identity and payment. By authenticating identity through fingerprint biometrics rather than passwords, PINs or traditional credentials, IDEX enables secure and convenient access to physical and digital services. Fingerprint matching happens directly on the card, offline and without transmitting biometric data. Certified by Visa, Mastercard, FIDO2 and EAL6+, and backed by more than 250 patents and over USD 350 million invested in R&D, IDEX serves banks, enterprises and public sector organizations directly and through channel partners worldwide.
IMPORTANT INFORMATION
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Kjell-Arne Besseberg, CEO of IDEX Biometrics ASA, on the date and the time set out above.
Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "strategy", "intends", "estimate", "will", "may", "continue", "should" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although IDEX believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control.
The information, opinions and forward-looking statements contained in this announcement speak only as at its date and are subject to change without notice. IDEX undertakes no obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this announcement.
This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of IDEX.